News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Astellas Pharma Inc. (YPH.BE) Partners With CUOG to Advance Uro-Oncology Research in Canada


4/17/2013 10:01:11 AM

MARKHAM, ON, April 17, 2013 /CNW/ - Genitourinary cancer research in Canada will receive additional funding thanks to a new research collaboration between the Canadian Urologic Oncology Group (CUOG) and Astellas Pharma Canada, Inc. (Astellas). This year, Astellas has pledged $50,000 to further Canadian investigators' peer-reviewed research into finding medicines and cures for urological disorders, focusing specifically on prostate cancer.

Read at Canada NewsWire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES